Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Clinical Transplantation
|
July 16, 2017
Outcomes of patients diagnosed with acute myeloid leukemia after solid organ transplantation
Konstantinos Lontos, Mounzer Agha, Anastasios Raptis, et al.
Leukemia & Lymphoma
|
September 8, 2022
A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML
Konstantinos Lontos, Anastasia Tsagianni, Mounzer Agha, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 25, 2021
A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy
Christi McKeown, Asha Ricciuti, Mounzer Agha, et al.
Leukemia & Lymphoma
|
February 1, 2023
Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy
Konstantinos Lontos, Anastasia Tsagianni, Mounzer Agha, et al.
American Journal of Hematology
|
January 23, 2024
Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients
Annie Im, Kevin Quann, Mounzer Agha, et al.
Leukemia & Lymphoma
|
April 5, 2018
A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia
Robert L Redner, Jan H Beumer, Patricia Kropf, et al.
Haematologica
|
August 8, 2024
A phase II study of post-remission therapy with pembrolizumab in older patients with acute myeloid leukemia
Kevin Quann, Konstantinos Lontos, Alison Sehgal, et al.
Cytotherapy
|
September 3, 2017
Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia
Michael Boyiadzis, Mounzer Agha, Robert L Redner, et al.
Lancet (London, England)
|
February 5, 2008
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
David J Kuter, James B Bussel, Roger M Lyons, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 25, 2025
Ziftomenib in Relapsed or Refractory <i>NPM1</i>-Mutated AML
Eunice S Wang, Pau Montesinos, James Foran, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Clinical Transplantation
|
July 16, 2017
Outcomes of patients diagnosed with acute myeloid leukemia after solid organ transplantation
Konstantinos Lontos, Mounzer Agha, Anastasios Raptis, et al.
Leukemia & Lymphoma
|
September 8, 2022
A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML
Konstantinos Lontos, Anastasia Tsagianni, Mounzer Agha, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 25, 2021
A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy
Christi McKeown, Asha Ricciuti, Mounzer Agha, et al.
Leukemia & Lymphoma
|
February 1, 2023
Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy
Konstantinos Lontos, Anastasia Tsagianni, Mounzer Agha, et al.
American Journal of Hematology
|
January 23, 2024
Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients
Annie Im, Kevin Quann, Mounzer Agha, et al.
Leukemia & Lymphoma
|
April 5, 2018
A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia
Robert L Redner, Jan H Beumer, Patricia Kropf, et al.
Haematologica
|
August 8, 2024
A phase II study of post-remission therapy with pembrolizumab in older patients with acute myeloid leukemia
Kevin Quann, Konstantinos Lontos, Alison Sehgal, et al.
Cytotherapy
|
September 3, 2017
Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia
Michael Boyiadzis, Mounzer Agha, Robert L Redner, et al.
Lancet (London, England)
|
February 5, 2008
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
David J Kuter, James B Bussel, Roger M Lyons, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 25, 2025
Ziftomenib in Relapsed or Refractory <i>NPM1</i>-Mutated AML
Eunice S Wang, Pau Montesinos, James Foran, et al.
Page
of 5